May 21, 2024, 05:24
Kim Jones: Fennec Pharmaceuticals Inc and TCAF are working together to raise awareness of ototoxicity from Cisplatin
Kim Jones, CEO and Founder at Testicular Cancer Awareness Foundation, shared a post on LinkedIn:
“Cisplatin is a life-saving drug when it comes to the treatment of testicular cancer, but it has the potential to cause ototoxicity (hearing loss).
Fennec Pharmaceuticals Inc and Testicular Cancer Awareness Foundation (TCAF) are working together to raise awareness of ototoxicity and the options available to mitigate the possibility of hearing loss.
New episode of It Takes Balls out now!
Thank you Eric Meyer, Fennec Pharmaceuticals and Testicular Cancer Awareness Foundation.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 3, 2024, 13:26
Dec 3, 2024, 11:53
Dec 3, 2024, 11:50
Dec 3, 2024, 11:43